Previous Article | Next Article 
Journal of Clinical Microbiology, November 2000, p. 4102-4107, Vol. 38, No. 11
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Mycobacterium heckeshornense sp. nov., a
New Pathogenic Slowly Growing Mycobacterium sp. Causing
Cavitary Lung Disease in an Immunocompetent Patient
Andreas
Roth,1,*
Udo
Reischl,2
Nicolas
Schönfeld,3
Ludmila
Naumann,2
Stefan
Emler,4
Marga
Fischer,1
Harald
Mauch,1
Robert
Loddenkemper,3 and
Reiner M.
Kroppenstedt5
Institut für Mikrobiologie und
Immunologie1 and Pneumologie
II,3 Lungenklinik Heckeshorn, 14109 Berlin, Institut für Medizinische Mikrobiologie und Hygiene,
Universität Regensburg, 93053 Regensburg,2
and Deutsche Sammlung von Mikroorganismen und Zellkulturen
GmbH, 38124 Braunschweig,5 Germany, and
Medica Medizinische Laboratorien, 8024 Zürich,
Switzerland4
Received 15 May 2000/Returned for modification 15 July
2000/Accepted 28 August 2000
 |
ABSTRACT |
A pathogenic scotochromogenic Mycobacterium xenopi-like
organism was isolated from the lung of an immunocompetent young woman. This pathogen caused severe bilateral cavitary lung disease, making two
surgical interventions necessary after years of chronic disease. This
case prompted us to characterize this mycobacterium by a polyphasic
taxonomic approach. The isolate contained chemotaxonomic markers which
were typical for the genus Mycobacterium, i.e., the
meso isomer of 2,6-diaminopimelic acid, arabinose, and
galactose as diagnostic whole-cell sugars, MK-9(H2) as the
principal isoprenoid quinone, a mycolic acid pattern of
-mycolates,
ketomycolates, and wax ester mycolates, unbranched saturated and
unsaturated fatty acids plus a significant amount of tuberculostearic
acid, and small amounts of a C20:0 secondary alcohol. On
the basis of its unique 16S rRNA and 16S-23S spacer gene sequences, we
propose that the isolate should be assigned to a new species,
Mycobacterium heckeshornense. This novel species is
phylogenetically closely related to M. xenopi. The type
strain of M. heckeshornense is strain S369 (DSM
44428T). The GenBank accession number of the 16S rRNA gene
of M. heckeshornense is AF174290.
 |
INTRODUCTION |
The suborder
Corynebacterineae of the order Actinomycetales,
class Actinobacteria, constitutes a phylogenetically
coherent group which includes the genera Corynebacterium,
Dietzia, Rhodococcus, Nocardia,
Skermania, Gordonia, Tsukamurella,
Williamsia, and Mycobacterium (8, 27).
These genera can easily be differentiated from other bacteria by a
combination of chemical markers, such as meso-diaminopimelic acid in the cell wall and the heteropolysaccharide arabinogalactan, which connects the mycolic acids (alpha-branched, beta-hydroxylated long-chain fatty acids) with the cell wall. Individual genera of the
Corynebacterineae can be differentiated via lipid cell wall
analysis, e.g., the chain length and type of mycolic acids, the type of
quinone, and the qualitative and quantitative differences in their
fatty acid patterns.
The present study characterizes a novel scotochromogenic mycobacterium
repeatedly isolated from the respiratory tract of an immunocompetent
woman treated at the Heckeshorn Lung Clinic, Berlin, Germany. As shown
by chemotaxonomic data, the isolates fell into a defined cluster of
slowly growing scotochromogenic mycobacteria which includes
Mycobacterium xenopi and Mycobacterium botniense. The phylogenetic analysis and biochemical tests showed that this isolate represents a new species of the genus Mycobacterium
for which the name Mycobacterium heckeshornense is proposed.
 |
MATERIALS AND METHODS |
Case report.
In March 1993 a 30-year-old Caucasian
woman with an inconspicuous medical history complained of cough and
fatigue. Chest X ray revealed a cavitation in the right upper lobe as
well as an infiltrate in the left upper lobe. The finding of
Staphylococcus aureus and a negative tuberculin skin test
led to nonspecific antibiotic treatment with doxycycline. The
left-sided infiltrate then disappeared and the cavitary lesion shrank.
At the end of 1993 the patient experienced a clinical relapse with
additional weight loss. Another antibiotic treatment with a
cephalosporin led again to temporary clinical and radiological
improvement. In October 1994, when the patient was admitted to the
Heckeshorn Lung Clinic for the first time, a chest X ray revealed an
enlargement of the right-sided cavitary lesion and again an infiltrate
in the left upper lobe. Sputum smears were negative for acid-fast bacilli, while bronchoscopy yielded acid-fast bacilli from the right
upper lobe. Mycobacteria were cultured, and the isolate was identified
as an M. xenopi-like organism by conventional biochemical methods. A biopsy from the right upper lobe histologically revealed epithelioid cell granulomatosis. Treatment with isoniazid, rifampin, protionamide, ethambutol, and ciprofloxacin was initiated. During this
treatment, the patient improved clinically, but only a moderate regression of the bilateral lesions was observed radiologically. The
organism was isolated repeatedly from microscopically positive sputum
samples for 2 months; thereafter, sputum cultures remained negative.
The treatment was continued for 1 year. The search for an underlying
immunological disorder was negative. There was a normal distribution of
cells in white blood cell counts as well as lymphocyte subsets.
Immunoglobulin G subclass concentrations in serum were not decreased.
Antibodies to human immunodeficiency virus were not found in serum.
Esophagography and gastroscopy did not show any signs of reflux or
hernia. No metabolic disorder was diagnosed.
In 1996, the patient complained of hemoptysis. Sputum cultures again
became positive for mycobacteria. With persisting cavitation in the
right upper lobe, additional aspergillus infection was suspected, which
was confirmed by culture in another hospital. Additionally, a
cavitation in the left upper lobe had been documented since November
1996. Antimycobacterial treatment plus itraconazole was administered
for 12 months, and then right upper lobe resection was performed in
October 1997. Resection of the left upper lobe was planned for January
1998 but was delayed because of repeated positive sputum smears
postoperatively. After continued antimycobacterial treatment, resection
was performed in January 1999 at our hospital. This lung specimen again
contained masses of acid-fast bacilli. In view of the clinically
obvious virulence of this mycobacterium, antimycobacterial treatment
was continued, and mycobacterial cultures have remained negative to the present.
Culture, biochemical tests, and drug susceptibility.
Among
several isolates recovered from this patient, two isolates (isolates
S369T and S532) were chosen for detailed analysis. Of
these, S369T was isolated from the first sputum specimen in
October 1994 and S532 was obtained in January 6 years later from a lung
biopsy specimen. Strain S504 was found in May 1999 in one of two sputum specimens from a second patient with chronic obstructive lung disease.
The latter finding was interpreted as a transient colonization according to the recommendations of the American Thoracic Society (30). Specimens were stained, processed, and cultured by
standard procedures in mycobacteriology (22). For fatty and
mycolic acid analyses, isolates S369T, S532, and S504 were
cultivated on Middlebrook 7H10 agar, supplemented with Middlebrook
oleic acid-albumin-dextrose-catalase (Difco Laboratories, Detroit,
Mich.) at 37°C for 2 weeks. The isolates were cultured for 4 weeks on
Löwenstein-Jensen (L-J) medium at 37°C and tested for growth
rate, for pigment production, and by all of the biochemical tests
listed in Table 1 by standard methods (9, 15). Acetamidase, allantoinase, benzamidase, nicotinamidase, pyrazinamidase,
succinamidase, and urease activities were determined by the method of
Bönicke (1). Susceptibility to isoniazid,
streptomycin, rifampin, ethambutol, p-aminosalicylic acid,
prothionamide, capreomycin, cycloserine, ciprofloxacin, and
clarithromycin was determined on L-J medium and was interpreted by the
modified proportion method (3, 4).
Determination of chemotaxonomic properties.
Amino acids and
sugars of whole-cell hydrolysates were analyzed by thin-layer
chromatography (TLC) as described previously (28).
Isoprenoid quinones were extracted by the small-scale integrated
procedure described by Minnikin et al. (18). Menaquinones were studied by high-performance liquid chromatography (HPLC) as
previously described in detail (11, 21, 26). Fatty acid methyl esters were obtained by saponification, methylation, and extraction, separated by gas-liquid chromatography (GLC), and determined by using the Microbial Identification System standard software package (21; M. Sasser, Identification of
bacteria by gas chromatography of cellular fatty acids, MIDI technical note 101, MIDI, Newark, Del., 1990). Freeze-dried bacteria (50 mg) were
degraded by treatment at 75°C with a mixture (3 ml) of methanol-toluene-sulfuric acid (30:15:1; vol/vol) for 16 h, and the hexane extracts were examined by TLC and two-dimensional
chromatography (16, 19, 21, 26). For mycolic acid analysis
by HPLC, 40 mg (wet weight) of cells was harvested from petri dishes.
The cells were suspended in an alkaline solution (25% KOH) and
saponified by heating to cleave the mycolic acids bound to the cell
walls. The mycolic acids were then obtained by acidification and
extraction into chloroform and then converted to their
p-bromophenacyl esters as described previously
(2; J. L. Miller, Sherlock mycobacteria identification by high-performance liquid chromatography, A training manual, MIDI, 1997). Low- and high-molecular-weight internal standards (Ribi ImmunoChem Research, Hamilton, Mont.) were added to the samples.
The mycolic acid p-bromophenacyl ester mixtures were separated by HPLC fitted with a C18 Ultrasphere-XL
cartridge column (Beckman Instruments Inc., Berkeley, Calif.) at
35°C. The chromatograph for HPLC was operated by Sherlock System
software (MIDI). The same procedure used for preparation of fatty acids
was used for preparation of the mycolic acid methyl esters. Ten
microliters of 0.2 M methanolic trimethylsulfonium hydroxide was added
to the extract to enhance the pyrolysis of the mycolic acid esters in
the injector block of the chromatograph for GLC heated at 350°C. For
the analysis of the mycolic acid cleavage products, GLC conditions were
used as described previously (20).
Analysis of ribosomal gene sequences.
PCR-based
amplification of strains S369T and S504 and sequencing of
the nearly complete 16S rRNA gene (rDNA) (both strands) were performed
as described before (21, 26). Isolate S532 was identified by
partial sequencing of the variable regions A and B only
(23). The sequence of the new strain was aligned with 48 mycobacterial 16S rDNA reference sequences by using the Genetic Data
Environment software, version 2.2 (12). No gaps were
removed, and probable sequencing errors within the reference sequences
were not weighted. A phylogenetic tree was constructed by using the
neighbor-joining method (25) and was applied to distances
corrected for multiple hits and for unequal transition and transversion
rates according to Kimura's two-parameter model (10), thus
omitting parts of uncertain alignment at both ends of the gene. Tree
positions were confirmed by parsimony analysis. Bootstrapping was not
performed due to the high degree of resemblance of mycobacterial 16S rDNA.
Additionally, we sequenced the 16S-23S spacer of strain
S369
T and S504 by the protocol used previously
(
23). Sequences were
compared with known spacer sequences by
applying a BLAST search.
The closest hits were selected for sequence
similarity analysis
by using the maximum matching option within the
DNASIS software
(version 2.5; Hitachi Software Engineering Co., Ltd.,
San Bruno,
Calif.).
Nucleotide sequence accession number.
The nucleotide
sequence of the 16S rDNA of strain S369T has been deposited
in GenBank database under accession number AF174290.
 |
RESULTS AND DISCUSSION |
Microbiological and clinical findings.
Growth of isolates
S369T, S532, and S504 was observed on L-J slants and
Middlebrook media (7H10, 7H11 agar, and 12B broth), whereas the
bacteria preferred Middlebrook to the egg-based medium (L-J was a very
poor supporter of growth for isolate S532). Small scotochromogenic,
yellow, round, smooth colonies (diameter, 0.5 mm) were visible after 4 weeks of growth at temperatures ranging from 37 to 45°C.
Microscopically, the cells presented as gram-positive, non-spore-forming, acid-alcohol-fast, nonmotile, pleomorphic rods. These findings, together with the biochemical properties shown in Table
1, indicated that the isolates
phenotypically resembled M. xenopi. The lack of
arylsulfatase, nicotinamidase, and pyrazinamidase enzyme activities,
however, was in discordance with the characteristics of M. xenopi. Reactions at variance to those for M. botniense, a saprophytic mycobacterium closely related to M. xenopi recently found in stream water (29), were tests
for 10-day arylsulfatase, heat-stable catalase, and pyrazinamidase
activities. Strains S369T and S504 showed resistance to
isoniazid, while isolate S532 was also resistant to rifampin, probably
due to acquired resistance.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Growth and biochemical characteristics of isolates
assigned to M. heckeshornense sp. nov. compared to those
of M. xenopia
|
|
The mycobacteria described in this report were isolated from two
patients suffering from lung disease. Although we cannot
with complete
certainty exclude an underlying unrecognized immunological
disorder in
the first patient, this case clearly meets criteria
that strongly
suggest the high potential pathogenicity of
M. heckeshornense for patients with or without preexisting lung
disease. Similar
to other nontuberculous mycobacteria that cause
pulmonary infections,
including
M. xenopi, which is a
well-recognized opportunistic
pathogen of the lung (
6),
M. heckeshornense shows the ability
to appear both as a
transient colonizer and as a severe pathogen
causing multiple lung
cavities. Unfortunately, precise identification
of nontuberculous
mycobacteria, especially by molecular biology-based
methods, is not
widely established in routine microbiological
laboratories, and
M. xenopi is often considered nonpathogenic
(
7).
It may be that this novel species has previously been
misidentified as
M. xenopi on the basis of poor phenotypic markers
(or a
tendency to assign uncertain species to one of the well-established
taxa) and occurs in human specimens more frequently than expected.
This
assumption is supported by the fact that, during this study,
we have
found a 16S rDNA sequence entry in the GenBank database
of an organism
provisionally named
M. xenopi (submitted January
2000, accession number
AJ243481) which is identical to the
sequence of
M. heckeshornense. To our knowledge this isolate caused
extrapulmonary infection. A detailed report on this case will
follow
shortly.
In conclusion, our study complements reports on the potential
pathogenicity of nontuberculous mycobacteria, including many
of those
in the increasing list of new species described in recent
years, and
again points to the importance of precise identification
of
mycobacteria, irrespective of the common belief that they mainly
occur
as
contaminants.
Chemotaxonomy.
The amino acid and sugar analyses of whole-cell
hydrolysates of the three isolates revealed
meso-diaminopimelic acid, arabinose, and galactose. This
combination of chemical markers grouped these isolates into the type IV
cell wall actinomycetes (14). The occurrence of mycolic
acids in whole-cell methanolysates classified S369T, S532,
and S504 in the order Actinomycetales, suborder
Corynebacterineae (27). The combination of
long-chain mycolic acids and the isoprenoid quinone
MK-9(H2) identified the strains as members of the genus Mycobacterium. A further differentiation within the genus
Mycobacterium was obtained by separating mycolic acids by
TLC in two directions. The analyses revealed four spots which could be
identified as
-mycolates, ketomycolates, and
-carboxymycolates
plus alcohols (wax ester mycolates). This pattern is widely distributed
among mycobacteria (5, 15). The gas chromatographic analyses
of whole-cell methanolysates of the three isolates showed similar elution profiles (Table 2). The pattern
was mainly composed of unbranched saturated and unsaturated fatty acid
esters with chain lengths of 16 and 18 carbon atoms plus 10-methyl
branched tuberculostearic acid methyl ester. Substantial amounts of the
secondary alcohol 2-docosanol (not shown in Table 2) and smaller
amounts of 2-eicosanol could also be found. This combination of fatty
acids and alcohols classified the three isolates to the M. xenopi-M. botniense taxon (13, 29). The pyrolysis of
the mycolic acid methyl esters released a saturated fatty acid methyl
ester with a chain length of 26 carbon atoms. This is in accordance
with the data reported for M. xenopi and M. botniense (17, 29). S369T, S532, and S504
could be differentiated from M. xenopi by the lack of
decanoic acid (10:0) and dodecanoic acid (12:0) and from M. botniense by the missing multimethyl-eicosanoic acids (Table 2).
Dodecanoic acid had previously been found to be a significant marker of
M. xenopi, although 1 of 25 clinical strains in the report
of Torkko et al. (29) contained this compound.
Interestingly, this one isolate was found to have a 16S rDNA sequence
that differed from the M. xenopi rDNA sequence. The HPLC
mycolic acid elution profiles of the three isolates shown in Fig.
1 are undistinguishable from that of
M. xenopi (2). The HPLC mycolic acid elution
profile of M. botniense is very similar to that of M. xenopi (29).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Composition of fatty acid methyl esters derived from
whole-cell hydrolysates of M. heckeshornense sp. nov.
isolates and M. xenopi DSM 43995T
|
|

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 1.
HPLC mycolic acid patterns of the three M. heckeshornense sp. nov. isolates. IS, internal standards.
|
|
Phylogenetic analysis.
The complete 16S rDNA sequences of two
isolates and the partial rDNA sequence of one strain of this novel
species were identical and differed from all available 16S rDNA
sequences. An alignment of relevant variable regions with those of a
selection of other mycobacteria is shown in Fig.
2. Sequence similarity analysis revealed
that the sequence was closest to M. xenopi (accession numbers X52929 and M61664) and M. botniense (accession
number AJ012756), showing as many as 41 mismatches with the former and
40 mismatches plus 3 gaps with the latter (sequence homology, 97% over
1,484 bases). A distance matrix tree inferred from analysis of the 16S
rDNA sequences of 48 mycobacteria is shown in Fig. 3. Both 16S-23S rDNA spacer sequences
obtained from strains S369T and S504 were also identical.
Although comparison with spacer sequences from M. xenopi and
M. botniense revealed a very high degree of sequence
divergence (Fig. 4), the spacer data
further confirmed the relationship to M. xenopi, both by
size (256 nucleotides compared to 235 and 273 nucleotides for M. xenopi and M. botniense, respectively) and by sequence
similarity (84% sequence similarity to M. xenopi and less
than 72% sequence similarity to M. botniense, M. shimoidei, or M. celatum). Thus, these data provide
additional evidence that 16S-23S spacer sequences can be implemented as
an adjunct in mycobacterial taxonomy (23). Besides this, the
importance of the spacer lies in its potential to be used as a
molecular tool for the identification of mycobacteria without the need
for sequencing. We recently described such a method based on
restriction fragment length polymorphism (RFLP) analysis of
PCR-amplified 16S-23S spacer sequences (24). Strains
S369T and S504 were included in that study and possessed
unique RFLP patterns distinguishable from those of all other
mycobacteria. Therefore, M. heckeshornense can easily be
detected without the need for sophisticated molecular biology-based
methods due to its unique spacer sequence.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 2.
Comparison of 16S rDNA signature sequences
(hypervariable regions A and B) of selected species of the genus
Mycobacterium including the novel species M. heckeshornense. Dots indicate identity, and hyphens represent
alignment gaps. The corresponding positions of the Escherichia
coli 16S rDNA are shown for reference. The sequence accession
numbers are as follows: M. tuberculosis, X58890; M. avium, X52918; M. celatum, L08170; M. shimoidei, AJ005005; M. nonchromogenicum, X52928;
M. triviale, X88924; M. xenopi, M61664; and
M. botniense, AJ012756.
|
|

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 3.
Phylogenetic tree indicating the relationship of
M. heckeshornense sp. nov. strain S369T to other
mycobacterial species. The tree was inferred by the neighbor-joining
method applied to distances corrected for multiple hits and for unequal
transition and transversion rates by Kimura's two-parameter model
(10). The tree was routed by using Nocardia
asteroides as an outgroup. The bar indicates the expected number
of substitutions per site.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 4.
Alignment of 16S-23S rDNA spacer sequences of M. heckeshornense sp. nov., M. xenopi DSM
43995T (23), and M. botniense ATCC
700701T (29). Dots indicate identity, and
hyphens represent alignment gaps. The lengths of the spacers (in
nucleotides) are indicated at the ends of the sequences.
|
|
Differentiation of M. heckeshornense sp. nov. from
other slowly growing mycobacteria.
The results of physiological
and phylogenetic analyses and some of the chemotaxonomic results
indicate that strain S369T represents a new species of the
genus Mycobacterium. The phylogenetic position of this so
far unclassified organism is within the cluster defined by M. xenopi and M. botniense. All three species synthesize
-mycolates, ketomycolates, and wax ester mycolates and release a
hexacosanoic pyrolysis ester from their mycolic acids. Key features are
negative tests for arylsulfatase and pyrazinamidase and susceptibility to antimycobacterial drugs. Since M. heckeshornense closely
resembles M. xenopi in fatty acid and mycolic acid analyses,
a definite separation from M. xenopi is obtained by its
unique 16S or 16S-23S rDNA sequences.
Description of M. heckeshornense sp. nov.
Mycobacterium heckeshornense (he.ckes.hor.nen'se; L.n. adj.,
a peninsula in Berlin, Germany, referring to the place where the
hospital in which the strain was found is situated). The cells are
gram-positive, non-spore-forming, nonmotile short rods that are
partially coccoid without branching. Smooth, scotochromogenic colonies
with a yellow color appear after 4 weeks of culture. The pigment
formation is weaker than the intense pigmentation usually seen in
M. xenopi. The cells are able to grow in a range of 37 to
45°C, but growth was best supported at 42°C. The cell wall of the
strain contains arabinose and galactose as major cell wall sugars.
meso-Diaminopimelic acid is the only cell wall diamino acid.
The only isoprenoid quinone is MK-9(H2). The fatty acid pattern from whole-cell methanolysates is composed of tetradecanoic acid (5.6 to 7.5%), palmitoleic acid (1%),
cis-10-hexadecenoic acid (2%), palmitic acid (45%), oleic
acid (7.4 to 9.6%), stearic acid (7.5%), and tuberculostearic acid
(19 to 21%). The secondary alcohols 2-eicosanol and 2-docosanol are
also present. TLC of mycolic acid methanolysates revealed
-mycolates, ketomycolates, wax carboxymycolates, and 2-eicosanol
(wax ester mycolates). The mycolic acid HPLC elution profile of
M. heckeshornense does not differ from that of the closely
related species M. xenopi. M. heckeshornense can safely be
identified by its unique ribosomal sequences and by negative 3-day
arylsulfatase and pyrazinamidase tests in conjunction with its
thermophilic growth behavior. Isolates S369T, S532, and
S504 have been deposited in the Deutsche Sammlung von Mikroorganismen
und Zellkulturen, Braunschweig, Germany, under accession numbers DSM
44428T, DSM 44483, and DSM 44482, respectively.
 |
ACKNOWLEDGMENTS |
We thank Gabriele Pötter and Michaela Schmidt for expert
technical assistance during the study.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute
für Mikrobiologie und Immunologie, Lungenklinik Heckeshorn, Zum
Heckeshorn 33, D 14109 Berlin, Germany. Phone: 49-30-8002 2254. Fax:
49-30-8002 2299. E-mail: mikromau{at}zedat.fu-berlin.de.
 |
REFERENCES |
| 1.
|
Bönicke, R.
1962.
Identification of mycobacteria by biochemical methods.
Bull. Int. Union Tuberc.
32:13-86.
|
| 2.
|
Butler, W. R.,
L. Thilbert, and J. O. Kilburn.
1992.
Identification of Mycobacterium avium complex strains and some similar species by high-performance liquid chromatography.
J. Clin. Microbiol.
30:2698-2704[Abstract/Free Full Text].
|
| 3.
|
Deutsches Institut für Normung.
1991.
DIN 58943, parts 3, 8, and 9.
Beuth Verlag, Berlin, Germany.
|
| 4.
|
Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose.
1991.
Die Bakteriologie der Tuberkulose.
Pneumologie
45:753-774.
|
| 5.
|
Hinrikson, H. P., and G. E. Pfyffer.
1994.
Mycobacterial mycolic acids.
Med. Microbial Lett.
3:49-57, 97-106.
|
| 6.
|
Hoffner, S. E.
1994.
Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria.
Eur. J. Clin. Microbiol. Infect. Dis.
3:937-941.
|
| 7.
|
Jiva, T. M.,
H. M. Jacoby,
L. A. Weymouth,
D. A. Kaminski, and A. C. Portmore.
1997.
Mycobacterium xenopi: innocent bystander or emerging pathogen?
Clin. Infect. Dis.
24:226-232[Medline].
|
| 8.
|
Kämpfer, P.,
M. A. Andersson,
F. A. Rainey,
R. M. Kroppenstedt, and M. Salkinoja-Salonen.
1999.
Williamsia muralis gen. nov., sp. nov., isolated from indoor environment of children's day care centre.
Int. J. Syst. Bacteriol.
49:681-687[Abstract/Free Full Text].
|
| 9.
|
Kent, P. T., and G. P. Kubica.
1985.
Public health mycobacteriology a guide for the level III laboratory. U.S. Department of Health and Human Services Publication (CDC) 86-8230.
Centers for Disease Control, Atlanta, Ga.
|
| 10.
|
Kimura, M.
1980.
A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences.
J. Mol. Evol.
16:111-120[CrossRef][Medline].
|
| 11.
|
Kroppenstedt, R. M.
1985.
Fatty acid and menaquinone analysis of actinomycetes and related organisms.
Soc. Appl. Bacteriol. Tech. Ser.
20:173-199.
|
| 12.
|
Larsen, N.,
G. J. Olsen,
B. L. Maidak,
M. J. McCaughey,
R. Overbeek,
T. Macke,
T. L. Marsh, and C. Woese.
1993.
The ribosomal database project.
Nucleic Acids Res.
21:3021-3023[Abstract/Free Full Text].
|
| 13.
|
Larsson, L.,
J. Jimenez,
P. Valero-Guillen,
F. Martin-Luengo, and M. Kubin.
1989.
Establishment of 2-docosanol as a cellular marker compound in the identification of Mycobacterium xenopi.
J. Clin. Microbiol.
27:2388-2390[Abstract/Free Full Text].
|
| 14.
|
Lechevalier, H. A., and M. P. Lechevalier.
1970.
A critical evaluation of the genera of aerobic actinomycetes, p. 393-405.
In
H. Prauser (ed.), The Actinomycetales. Gustav Fischer Verlag, Jena, Germany.
|
| 15.
|
Lévy-Frébault, V. V., and F. Portales.
1992.
Proposed minimal standards for the genus Mycobacterium and for description of new slowly growing Mycobacterium species.
Int. J. Syst. Bacteriol.
42:315-323[Abstract/Free Full Text].
|
| 16.
|
Luquin, M.,
V. Ausina,
F. L. Calahorra,
F. Belda,
M. G. Barcelona,
C. Celma, and G. Prats.
1991.
Evaluation of practical chromatographic procedures for identification of clinical isolates of mycobacteria.
J. Clin. Microbiol.
29:120-130[Abstract/Free Full Text].
|
| 17.
|
Luquin, M.,
F. Lopez, and V. Ausina.
1989.
Capillary gas chromatographic analysis of mycolic acid cleavage products, cellular fatty acids, and alcohols of Mycobacterium xenopi.
J. Clin. Microbiol.
27:1403-1406[Abstract/Free Full Text].
|
| 18.
|
Minnikin, D. E.,
A. G. O'Donnell,
M. Goodfellow,
G. Alderson,
M. Athalye,
A. Schaal, and J. H. Parlett.
1984.
An integrated procedure for the extraction of isoprenoid quinones and polar lipids.
J. Microbiol. Methods
2:233-241[CrossRef].
|
| 19.
|
Minnikin, D. E.,
I. G. Hutchinson,
A. B. Caldicott, and M. Goodfellow.
1980.
Thin-layer chromatography of methanolysates of mycolic acid-containing bacteria.
J. Chromatogr.
188:221-233[CrossRef].
|
| 20.
|
Müller, K.-D.,
E. N. Schmid, and R. M. Kroppenstedt.
1998.
Improved identification of mycobacteria by using the Microbial Identification System in combination with additional trimethylsulfonium hydroxide pyrolysis.
J. Clin. Microbiol.
36:2477-2480[Abstract/Free Full Text].
|
| 21.
|
Reischl, U.,
S. Emler,
Z. Horak,
J. Kaustova,
R. M. Kroppenstedt,
N. Lehn, and L. Naumann.
1998.
Mycobacterium bohemicum sp. nov., a new slow-growing scotochromogenic mycobacterium.
Int. J. Syst. Bacteriol.
48:1349-1355[Abstract/Free Full Text].
|
| 22.
|
Roberts, E. D.,
E. W. Koneman, and Y. K. Kim.
1991.
Mycobacterium, p. 304-339.
In
A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
|
| 23.
|
Roth, A.,
M. Fischer,
H. E. Hamid,
W. Ludwig,
S. Michalke, and H. Mauch.
1998.
Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences.
J. Clin. Microbiol.
36:139-147[Abstract/Free Full Text].
|
| 24.
|
Roth, A.,
U. Reischl,
A. Streubel,
L. Naumann,
R. M. Kroppenstedt,
M. Habicht,
M. Fischer, and H. Mauch.
2000.
Novel diagnostic algorithm for identification of mycobacteria using genus-specific amplification of the 16S-23S rRNA gene spacer and restriction endonucleases.
J. Clin. Microbiol.
38:1094-1104[Abstract/Free Full Text].
|
| 25.
|
Saitou, N., and M. Nei.
1987.
The neighbor-joining method: a new method for reconstructing phylogenetic trees.
Mol. Biol. Evol.
4:406-425[Abstract].
|
| 26.
|
Schröder, K.-H.,
L. Naumann,
R. M. Kroppenstedt, and U. Reischl.
1997.
Mycobacterium hassiacum sp. nov., a new rapidly growing thermophilic mycobacterium.
Int. J. Syst. Bacteriol.
47:86-91[Abstract/Free Full Text].
|
| 27.
|
Stackebrandt, E.,
F. A. Rainey, and N. L. Ward-Rainey.
1997.
Proposal for a new hierarchic classification system, Actinobacteria classis nov.
Int. J. Syst. Bacteriol.
47:479-491[Abstract/Free Full Text].
|
| 28.
|
Stanek, J. L., and G. D. Roberts.
1974.
Simplified approach to identification of aerobic actinomycetes by thin-layer chromatography.
Appl. Microbiol.
28:226-231[Medline].
|
| 29.
|
Torkko, P.,
S. Suomalainen,
E. Iivavanen,
M. Suutari,
E. Tortoli,
L. Paulin, and M.-L. Katila.
2000.
Mycobacterium xenopi and related organisms isolated from stream waters in Finland and description of Mycobacterium botniense sp. nov.
Int. J. Syst. Evol. Microbiol.
50:283-289[Abstract].
|
| 30.
|
Wallace, R. J., Jr.,
R. O'Brien,
J. Glassroth,
J. Raleigh, and A. Dutt.
1990.
Diagnosis and treatment of disease caused by nontuberculous mycobacteria.
Am. Rev. Respir. Dis.
142:940-953[Medline].
|
Journal of Clinical Microbiology, November 2000, p. 4102-4107, Vol. 38, No. 11
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
ELYOUSFI, A. A., LEITER, J. R.S., GOYTAN, M. J., ROBINSON, D. B.
(2009). Mycobacterium heckeshornense Lumbar Spondylodiskitis in a Patient with Rheumatoid Arthritis Receiving Etanercept Treatment. The Journal of Rheumatology
36: 2130-2131
[Full Text]
-
van Ingen, J., Boeree, M. J., de Lange, W. C. M., de Haas, P. E. W., van der Zanden, A. G. M., Mijs, W., Rigouts, L., Dekhuijzen, P. N. R., van Soolingen, D.
(2009). Mycobacterium noviomagense sp. nov.; clinical relevance evaluated in 17 patients. Int. J. Syst. Evol. Microbiol.
59: 845-849
[Abstract]
[Full Text]
-
McBride, S. J., Taylor, S. L., Pandey, S. K., Holland, D. J.
(2009). First Case of Mycobacterium heckeshornense Lymphadenitis. J. Clin. Microbiol.
47: 268-270
[Abstract]
[Full Text]
-
Schonfeld, N.
(2006). The mycobacterial mystery. Eur Respir J
28: 1076-1078
[Full Text]
-
van Hest, R., van der Zanden, A., Boeree, M., Kremer, K., Dessens, M., Westenend, P., Maraha, B., van Uffelen, R., Schutte, R., de Lange, W.
(2004). Mycobacterium heckeshornense Infection in an Immunocompetent Patient and Identification by 16S rRNA Sequence Analysis of Culture Material and a Histopathology Tissue Specimen. J. Clin. Microbiol.
42: 4386-4389
[Abstract]
[Full Text]
-
McNabb, A., Eisler, D., Adie, K., Amos, M., Rodrigues, M., Stephens, G., Black, W. A., Isaac-Renton, J.
(2004). Assessment of Partial Sequencing of the 65-Kilodalton Heat Shock Protein Gene (hsp65) for Routine Identification of Mycobacterium Species Isolated from Clinical Sources. J. Clin. Microbiol.
42: 3000-3011
[Abstract]
[Full Text]
-
Levi, M. H., Bartell, J., Gandolfo, L., Smole, S. C., Costa, S. F., Weiss, L. M., Johnson, L. K., Osterhout, G., Herbst, L. H.
(2003). Characterization of Mycobacteriummontefiorense sp. nov., a Novel Pathogenic Mycobacterium from Moray Eels That Is Related to Mycobacteriumtriplex. J. Clin. Microbiol.
41: 2147-2152
[Abstract]
[Full Text]
-
Tortoli, E.
(2003). Impact of Genotypic Studies on Mycobacterial Taxonomy: the New Mycobacteria of the 1990s. Clin. Microbiol. Rev.
16: 319-354
[Abstract]
[Full Text]
-
Torkko, P., Katila, M.-L., Kontro, M.
(2003). Gas-chromatographic lipid profiles in identification of currently known slowly growing environmental mycobacteria. J Med Microbiol
52: 315-323
[Abstract]
[Full Text]
-
Richter, E., Niemann, S., Ruesch-Gerdes, S., Harmsen, D., Roth, A., Mauch, H., Schonfeld, N., Loddenkemper, R., Reischl, U., Naumann, L., Kroppenstedt, R. M.
(2001). Description of Mycobacterium heckeshornense sp. nov.. J. Clin. Microbiol.
39: 3023-3024
[Full Text]